Epilepsy is one of the most common serious mental disorders affecting about50million people each year. In the past decade, antiepleptic drugs were rapidly developed. However, almost one-third of epileptic patients still remain refractory to medication, suggesting a need for better antiepileptic drugs.We investigated the anticonvulsant effect of acute Fuzi total alkaloid (FTA) in seizure induced by the GABAA-receptor antagonist pentylenetetrazole (PTZ). FTA significantly increased the seizure latency and decreased the mortality in PTZ-treated mice. Administration of PTZ increased c-Fos expression in the hippocampus, medial prefrontal cortex, and piriform cortex; and this PTZ-induced effect was inhibited by FTA in a dose-dependent manner. Furthermore, the effects of FTA on PTZ-induced seizure and c-Fos expression were reversed by the GABAA/benzodiazepine-selective antagonist flumazenil. These findings suggest that the anticonvulsant effects of FTA may be ralated to modulation of GABAA-benzodiazepine receptor complex. |